Shopping Cart
- Remove All
- Your shopping cart is currently empty
Obrindatamab, a humanized anti-B7-H3/CD3 bispecific antibody, targets B7-H3 and CD3, facilitating redirected cytotoxic T-lymphocyte (CTL) activity towards B7-H3-expressing cancer cells. It is utilized in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $539 | 2-4 weeks | |
5 mg | $1,330 | 2-4 weeks | |
10 mg | $2,150 | 2-4 weeks |
Description | Obrindatamab, a humanized anti-B7-H3/CD3 bispecific antibody, targets B7-H3 and CD3, facilitating redirected cytotoxic T-lymphocyte (CTL) activity towards B7-H3-expressing cancer cells. It is utilized in cancer research [1]. |
Cas No. | 2069959-72-2 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.